Cleared Traditional

K902319 - BAUER TEMNO BIOPSY NEEDLE

K902319 is an FDA 510(k) clearance for BAUER TEMNO BIOPSY NEEDLE, manufactured by Proact, Ltd.. The device is a Class 2 Gastroenterology & Urology device with product code FCG cleared through the Traditional 510(k) pathway after a 106-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1990
Decision
106d
Days
Class 2
Risk

K902319 is an FDA 510(k) clearance for the BAUER TEMNO BIOPSY NEEDLE. Classified as Biopsy Needle (product code FCG), Class II - Special Controls.

Submitted by Proact, Ltd. (State College, US). The FDA issued a Cleared decision on September 6, 1990 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1075 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K902319

510(k) Number K902319 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 23, 1990
Decision Date September 06, 1990
Days to Decision 106 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
25d faster than avg
Panel avg: 131d · This submission: 106d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FCG Device Classification - Class 2, Special Controls

Product Code FCG Biopsy Needle
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1075
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FCG Biopsy Needle

All 132
Devices cleared under the same product code (FCG) and FDA review panel - the closest regulatory comparables to K902319.
HYPODERMIC NEEDLES, SINGLE LUMEN
K911397 · Popper & Sons, Inc. · May 1991
HIGH SPEED CORE CUT BIOPSY GUN
K905556 · Uni-Quatro Industries Canada, Inc. · Mar 1991
BAUER FLEXI-TEMNO BIOPSY NEEDLE
K902320 · Proact, Ltd. · Oct 1990
INGRESS TECHNOLOGIES AUTO BX BIOPSY NEEDLE
K896932 · The Witmoore Group, Inc. · Jun 1990
BIOPSY NEEDLE GUIDE FOR ADMS ULTRASOUND PROBES
K895725 · Interson Corp. · Nov 1989
MANAN PROSTATIC BIOPSY NEEDLE
K895897 · Manan Medical Products, Inc. · Oct 1989